Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01435265 · ClinicalTrials.gov registry record · NA
Nurse Education in Subjects With Psoriasis Undergoing Treatment With Adalimumab
A NA study, sponsored by Wake Forest University Health Sciences.
- Completed
- Registry status
- NA
- Development phase
- 7
- Enrollment target
NCT01435265: Completed NA study, sponsored by Wake Forest University Health Sciences.
NCT01435265 is a NA study that has completed, run by Wake Forest University Health Sciences. The registered enrollment target is 7 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (100% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01435265, a NA study, has completed, sponsored by Wake Forest University Health Sciences.
- COMPLETED
- Registry status
- NA
- Development phase
- 7 participants
- Enrollment target
Study Summary
This is a phase IV randomized, prospective open label study to asses the efficacy of an extended nurse eduction program in improving adherence to the prescribed treatment regimen in the treatment of moderate to severe psoriasis vulgaris.
Primary Outcome
The Psoriasis Area Severity Index measures severity of psoriasis on a 0-6 scale for head, trunk, upper extremities, and lower extremities and amount of erythema, infiltration, and desquamation for each area. An overall score of 0-72 for the whole body is calculated from the observed severity values. Outcomes will be reported in terms of PASI 75, or number of participants showing at least 75% reduction in PASI score from baseline. Only final PASI 75 will be reported.
Interventions
- BEHAVIORAL Standard nurse education
- BEHAVIORAL Additional nurse education
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 7 participants |
| Start Date | 2010-01 |
| Est. Completion | 2012-04 |
| Phase | NA |
What the finished NCT01435265 record still lists
NCT01435265 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 7 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (100% lower).
The record links to 0 conditions, and to 2 interventions - of which Standard nurse education is the first listed.
NCT01435265 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT01435265 about?
NCT01435265 is a clinical study titled "Nurse Education in Subjects With Psoriasis Undergoing Treatment With Adalimumab". This is a phase IV randomized, prospective open label study to asses the efficacy of an extended nurse eduction program in improving adherence to the prescribed treatment regimen in the treatment of moderate to severe psoriasis vulgaris.
What is the current status of trial NCT01435265?
This trial is currently completed. It is a NA study. The enrollment target is 7 participants. The study started on 2010-01. Estimated completion is 2012-04.
What interventions are being tested in trial NCT01435265?
The interventions under investigation include: Standard nurse education (BEHAVIORAL), Additional nurse education (BEHAVIORAL).
Who is sponsoring clinical trial NCT01435265?
This trial is sponsored by Wake Forest University Health Sciences, which has 1,140 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT01435265's enrollment target sits among peer trials
7 1982nd of 2000 higher than 18 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia